Markets

Eleven Biotherapeutics (EBIO) in Focus: Stock Rises 8.7% - Tale of the Tape

Eleven Biotherapeutics, Inc. ( EBIO ) was a big mover last session, as its shares rose almost 9% on the day. This led to more shares changing hands than in a normal session. Yesterday's rally continues the uptrend for the company since Apr 6, as the stock is now up over 28%.

Over the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Friday's price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Eleven Biotherapeutics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

A better-ranked biomedical stock is Affymetrix Inc. ( AFFX ) with a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days.Click to get this free report >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

ELEVEN BIOTHERP (EBIO): Free Stock Analysis Report

AFFYMETRIX INC (AFFX): Free Stock Analysis Report

To read this article on Zacks.com click here.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Latest Markets Videos

    Zacks

    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at www.zacks.com.

    Learn More